홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
GALT
#3040
Galectin Therapeutics Inc.
2.9
8
-1.32%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
-1.32%
월간 변동
-5.40%
6달 변화
-25.87%
년간 변동율
+104.11%
이전 종가
3.0
2
Open
2.9
8
Bid
Ask
Low
2.9
8
High
2.9
8
양
21
마켓
주식
헬스케어
GALT
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
62.76 M
63.18 M
63.29 M
64.06 M
64.47 M
—
Valuation ratios
Enterprise value
146.04 M
66.88 M
70.28 M
121.89 M
262.01 M
521.06 M
Price to earnings ratio
-3.77
-1.7
-1.69
-3.3
-7.18
-13.87
Price to sales ratio
455.96
136.7
-299.01
183.93
124.5
146.11
Price to cash flow ratio
-5.05
-1.92
-2.04
-3.71
-8.7
-16.37
Price to book ratio
-0.54
-0.76
-0.19
-0.31
-0.58
-1.84
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.39
0.68
1.01
0.48
0.64
2.81
Return on equity %
0.12
0.11
0.08
0.06
0.07
0.33
Return on invested capital %
—
—
—
—
—
—
Gross margin %
100
100
100
100
100
400
Operating margin %
1 203.98
-1 087.31
31.59 K
421.99
190.39
31.11 K
EBITDA margin %
—
—
—
—
—
—
Net margin %
1 490.04
-1 046.98
38.52 K
686.22
371.16
38.53 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
1.13
0.49
0.08
1.43
0.09
2.1
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.03
-0.05
0
0.09
0.15
0.19
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.14
0.21
0.12
0.1
0.05
0.49
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
0.43
0.24
0.12
0.22
0.18
0.76
Net current asset value per share
0.46
0.28
0.15
0.24
0.2
0.87
Tangible book value per share
1.5
1.67
1.8
1.87
1.94
7.28
Working capital per share
0.05
-0.29
-1.61
0.07
-1.93
-3.75
Book value per share
1.5
1.67
1.8
1.87
1.94
7.28
뉴스
갈락틴 테라퓨틱스 이사, 마크 루빈 사임
Galectin Therapeutics director Marc Rubin resigns from board
Galectin Therapeutics CFO, 23.3만 달러 상당 주식 매도
Galectin Therapeutics CFO sells $233k in shares
Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains
oracle, micron tech among market cap stock movers on friday
Galectin Therapeutics, FDA 피드백 후 주가 폭락
Galectin Therapeutics stock plummets after FDA feedback on drug
FDA provides feedback on Galectin’s belapectin development program
갈렉틴 테라퓨틱스 이사, 105만 달러 상당 주식 매도
갈렉틴 테라퓨틱스, 이사진 선임 및 주요 제안 승인
Clinical Progress Drives Galectin Shares Up Post-NAVIGATE Data (NASDAQ:GALT)